Prediabetes News and Research

RSS

One in three young people estimated to live with pediatric onset chronic conditions

The prevalence of chronic conditions has risen to unprecedented levels over the past twenty years, with nearly 1-in-3 young people estimated to now be living with pediatric onset conditions that significantly affect their lives, new research suggests.

10 Mar 2025

Artificial sweeteners may reduce metformin’s effectiveness in weight and glucose control

Drinking artificially sweetened beverages may reduce metformin’s effectiveness in young patients with obesity and prediabetes, but a larger study is needed to confirm these findings.

27 Feb 2025

New low-cost tool could revolutionize type 2 diabetes treatment

Millions of people with type 2 diabetes could receive better treatment thanks to a new, simple low-cost tool, according to groundbreaking research announced today at the Diabetes UK Professional Conference 2025 and published in the Lancet.

26 Feb 2025

Broccoli sprouts may help prediabetes, but only with the right gut bacteria

Broccoli sprout extract (BSE) modestly lowered fasting blood glucose in prediabetes, but its effectiveness depended on gut microbiota, particularly the BT2160 operon.

11 Feb 2025

Exercise improves brain insulin sensitivity and lowers dementia risk in older adults with prediabetes

Researchers explore the impact of exercise on the short-term regulation of insulin pathways in brain circuits.

28 Jan 2025

Researchers shed light on risk factor and diabetes development interplay

Findings indicate a 12.8% 10-year diabetes risk, driven by fasting plasma glucose, age, sex, and BMI, highlighting the need for targeted prevention strategies.

28 Jan 2025

Alarming cardiovascular disease statistics highlighted in 2025 report

Heart disease kills more people than any other cause as many of the risks factors that contribute to it remain on the rise, according the data reported in the 2025 Heart Disease and Stroke Statistics: A Report of U.S. and Global Data From the American Heart Association.

27 Jan 2025

Study shows how physical activity can enhance brain function and prevent dementia

A study led by scientists at Rutgers University-New Brunswick has shown that specialized cells involved in how the body responds to insulin are activated in the brain after exercise, suggesting that physical activity may directly improve brain function.

23 Jan 2025

AI-based tool identifies subtypes of Type 2 diabetes using glucose monitors

Diabetes has long been lumped into two categories - Type 1, which often appears in childhood, or Type 2, which is associated with obesity and typically develops later in life. But scientists have learned that not all patients with Type 2 diabetes are the same, with some patients varying in body weight, age of onset and other characteristics.

7 Jan 2025

DASH Diet earns top spots in 2025 U.S. News & World Report Best Diets Rankings

The Dietary Approaches to Stop Hypertension, or DASH, Diet, developed in part by Pennington Biomedical Research Center scientists, has been recognized as the second-best diet overall and the best heart-healthy diet in the 2025 U.S. News & World Report Best Diets Rankings.

6 Jan 2025

National Diabetes Prevention Program helps reduce medical costs

About 1 in 3 adults in the United States have prediabetes, a condition where blood glucose levels are higher than normal, but not high enough to be diagnosed as diabetes.

3 Jan 2025

Insulin degradation uncovered as a new driver of resistance

Researchers reveal insulin resistance may be driven by insulin degradation during transit in the bloodstream, challenging the belief that cell defects are the primary cause.

22 Dec 2024

Study finds no impact of high vitamin D doses on type 2 diabetes prevention

Using significantly higher doses of vitamin D than recommended for five years did not affect the incidence of type 2 diabetes in elderly men and women, according to a new study from the University of Eastern Finland.

3 Dec 2024

Tirzepatide cuts diabetes risk by 90% in obese patients, study shows

Tirzepatide, a new injectable weight-loss drug with the trade name Zepbound, reduced the risk of diabetes in patients with obesity and prediabetes by more than 90% over a three-year period, compared with placebo, according to the results of a new study led by investigators at Weill Cornell Medicine, NewYork-Presbyterian, Yale School of Medicine and other institutions.

26 Nov 2024